A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

Official Title: A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection

ClinicalTrials.gov ID: NCT03808922

Principal Investigator: Muller, William J., MD, PhD

Study Type: Interventional

Currently Recruiting Patients: Yes

Laura Fearn, RN

CRC

312-227-6285